Stock Region Watchlist Newsletter - Monday, March 31, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered as financial advice. Please consult with a licensed financial advisor before making any investment decisions.
$NWTG - Newton Golf Company

Newton Golf Company reported impressive financial results for Q4 and full-year 2024.
Q4 Revenue surged to $1.07 million, an 817% increase from $117,000 in Q4 2023.
Gross Margin expanded to 73%, significantly up from 36% in the same quarter last year.
Full-year revenue reached $3.445 million, marking an 887% year-over-year growth.
$PTN - Palatin Technologies
Palatin’s MC4R Agonist, Bremelanotide, co-administered with GLP-1/GIP Tirzepatide, met its primary endpoint in a Phase 2 obesity study. Promising results could lead to further advancements in treatments targeting obesity.
$BKYI - BIO-key
BIO-key has partnered with Arrow ECS Iberia, aiming to enhance access to its identity and access management solutions in Spain and Portugal. This collaboration is expected to strengthen BIO-key's position in European markets.
$BCDA - Biocardia
Biocardia’s Phase 3 CardiAMP-HF Trial for ischemic heart failure showed remarkable outcomes. Two-year data highlights increased survival, fewer cardiac events, and an improved quality of life for patients.
$THAR - Tharimmune
Tharimmune has received positive FDA feedback on its New Drug Application (NDA) path for TH104, targeting the prophylaxis of respiratory and/or CNS depression due to ultrapotent opioid exposure.
$MULN - Mullen Automotive
Mullen achieved a legal victory in its litigation over alleged stock manipulation. A federal judge denied IMC, Clear Street, and UBS’s motion to dismiss, allowing the case to proceed to full discovery. This significant decision could work in favor of Mullen and other affected companies.
$NMAX - Newsmax IPO

Newsmax Inc. completed its IPO today, opening for trading at $15 per share. Established in 1998, Newsmax has grown into a leading independent news media company catering to Americans’ demand for real news and opinions.
Disclaimer: All information provided in this newsletter is based on publicly available data and is accurate to the best of our knowledge. Stock investments involve risks, and past performance is not indicative of future results. Please exercise caution and perform your own due diligence before making investment decisions.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net